THIP) or a derivative thereof and a
pharmaceutically acceptable carrier or excipient to
increase tonic inhibition of neurons of the subject. "
16. The complete ... THIP) or a
derivative thereof and a pharmaceutically acceptable
carrier or excipient to increase tonic inhibition of
neurons in the subject, to increase slow wave
Sulphur Mills Limited vs Dharmaj Crop Guard Limited & Anr. on 18 March, 2024
Author
liquid composition comprising of Pendimethalin
and Metribuzin along with inactive excipients Octyl phenol ethoxylate,
Ethoxylated of poly aryl phenol, Propylene Glycol in oil phase ... term "comprising" thus indicating that the list of inert excipients is not
exhaustive
Active ingredients: Claim 1:
a) Pendimethalin
further
comprising combining the purified composition with one or more
pharmaceutically acceptable excipients to make a pharmaceutical
composition.
8. The method as claimed ... Pertuzumab and is in
relation to a Pertuzumab formulation comprising Pertuzumab and excipients
such as sucrose, histidine acetate buffer, polysorbate, such that
ingredient and 10% water content and the balance being active ingredients and excipients. Moreover, BPAC is occlusive in nature which is the property ... ingredients and 10% water content and balance active ingredients and excipients. Moreover, BPHSAC is occlusive in nature which is the property of an ointment
Compound (I), and
a pharmaceutically acceptable carrier, and may contain
conventional excipients. A therapeutically effective
amount is the amount needed to provide a meaningful
patient
Compound (I), and a
pharmaceutically acceptable carrier, and may contain
conventional excipients. A therapeutically effective
amount is the amount needed to provide a meaningful
patient
pharmaceutical ingredients, their intermediates and enteric coating
excipients and they export it to North America, Europe, Asia and Latin
America. The defendant is a general ... plaintiff is a manufacturer of pharmaceutical ingredients,
their intermediates and enteric coating excipients and they exports it North
America, Europe, Asia and Latin America
huge quantity of
allopathic spurious drugs (loose tablets), raw materials (API
and excipients), rubber stereos, scrap of foils and processed
material and the machineries
Plaintiff No. 2, relates to an aqueous pharmaceutical formulation comprising
Pertuzumab and excipients such as sucrose, histidine acetate buffer,
polysorbate, such that
